| Name | ethyl 2,3-dihydro-1,4-benzodioxine-6-carboxylate |
|---|---|
| Synonyms |
2,3-dihydro-benzo[1,4]dioxin-6-carboxylic acid ethyl ester
2,3-Dihydro-benzo[1,4]dioxin-6-carbonsaeure-aethylester ethyl 2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate 2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid ethyl ester |
| Molecular Formula | C11H12O4 |
|---|---|
| Molecular Weight | 208.21100 |
| Exact Mass | 208.07400 |
| PSA | 44.76000 |
| LogP | 1.63450 |
| Vapour Pressure | 0.001mmHg at 25°C |
| HS Code | 2932999099 |
|---|
|
~28%
20825-87-0 |
| Literature: Vertex Pharmaceuticals Incorported Patent: US2011/98311 A1, 2011 ; |
|
~%
20825-87-0 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 20, # 4 p. 1373 - 1379 |
| Precursor 4 | |
|---|---|
| DownStream 2 | |
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |